Modi Naturals Limited (BOM:519003)
India · Delayed Price · Currency is INR 414.95
-3.85 (-0.92%)
At close: Aug 7, 2025
Longboard Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 6,629 | 3,954 | 4,177 | 4,740 | 4,412 | Upgrade |
Other Revenue | - | 44.2 | 2.32 | 3.27 | 17.27 | Upgrade |
Revenue | 6,629 | 3,998 | 4,180 | 4,743 | 4,429 | Upgrade |
Revenue Growth (YoY) | 65.80% | -4.34% | -11.88% | 7.08% | 14.06% | Upgrade |
Cost of Revenue | 5,112 | 3,006 | 3,300 | 3,744 | 3,612 | Upgrade |
Gross Profit | 1,517 | 992.08 | 879.68 | 999.33 | 817.15 | Upgrade |
Selling, General & Admin | 311.87 | 277.65 | 248.16 | 235.64 | 225.64 | Upgrade |
Other Operating Expenses | 633.27 | 620.23 | 571.04 | 607.24 | 460.67 | Upgrade |
Operating Expenses | 1,023 | 940.02 | 834.77 | 857.1 | 700.13 | Upgrade |
Operating Income | 493.95 | 52.06 | 44.91 | 142.24 | 117.02 | Upgrade |
Interest Expense | -117.03 | -70.31 | -32.7 | -14.44 | -10.64 | Upgrade |
Interest & Investment Income | - | 5.92 | 0.88 | 0.53 | 0.95 | Upgrade |
Currency Exchange Gain (Loss) | - | 2 | 2.69 | 4.46 | 0.96 | Upgrade |
Other Non Operating Income (Expenses) | - | -6.99 | 2.33 | -3.61 | -1 | Upgrade |
EBT Excluding Unusual Items | 376.92 | -17.32 | 18.11 | 129.17 | 107.28 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.03 | 0.48 | 0.35 | 32.39 | Upgrade |
Pretax Income | 376.92 | -17.3 | 18.59 | 129.52 | 139.68 | Upgrade |
Income Tax Expense | 66.67 | -3.51 | 7.9 | 35.87 | 34.52 | Upgrade |
Net Income | 310.26 | -13.78 | 10.69 | 93.65 | 105.16 | Upgrade |
Net Income to Common | 310.26 | -13.78 | 10.69 | 93.65 | 105.16 | Upgrade |
Net Income Growth | - | - | -88.59% | -10.94% | 127.34% | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Change (YoY) | 5.44% | - | - | - | - | Upgrade |
EPS (Basic) | 23.25 | -1.09 | 0.84 | 7.40 | 8.31 | Upgrade |
EPS (Diluted) | 23.25 | -1.09 | 0.84 | 7.40 | 8.31 | Upgrade |
EPS Growth | - | - | -88.59% | -10.94% | 127.34% | Upgrade |
Free Cash Flow | 289.75 | -414.88 | -999.71 | -275.17 | 77 | Upgrade |
Free Cash Flow Per Share | 21.71 | -32.78 | -78.99 | -21.74 | 6.08 | Upgrade |
Gross Margin | 22.89% | 24.81% | 21.05% | 21.07% | 18.45% | Upgrade |
Operating Margin | 7.45% | 1.30% | 1.07% | 3.00% | 2.64% | Upgrade |
Profit Margin | 4.68% | -0.34% | 0.26% | 1.98% | 2.37% | Upgrade |
Free Cash Flow Margin | 4.37% | -10.38% | -23.92% | -5.80% | 1.74% | Upgrade |
EBITDA | 572.13 | 94.16 | 60.44 | 156.41 | 130.79 | Upgrade |
EBITDA Margin | 8.63% | 2.35% | 1.45% | 3.30% | 2.95% | Upgrade |
D&A For EBITDA | 78.17 | 42.1 | 15.53 | 14.17 | 13.77 | Upgrade |
EBIT | 493.95 | 52.06 | 44.91 | 142.24 | 117.02 | Upgrade |
EBIT Margin | 7.45% | 1.30% | 1.07% | 3.00% | 2.64% | Upgrade |
Effective Tax Rate | 17.69% | - | 42.51% | 27.69% | 24.71% | Upgrade |
Revenue as Reported | 6,641 | 4,010 | 4,197 | 4,756 | 4,466 | Upgrade |
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.